Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Mitapivat, sold under the brand name Pyrukynd among others, is a medication used to treat different types of anemia. It is taken as the sulfate hydrate salt by mouth. Mitapivat is a pyruvate kinase activator.
The analysis highlights Community, Culture, Applications and Products as prominent areas in the source structure around Mitapivat.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Mitapivat shows recurring relationship patterns in the source. For example, Mitapivat → Brazil, Canada, Denmark, Drug Administration, France, Germany, In Trial, Ireland, Italy, Japan, Korea, NCT03548220, NCT03559699, Neither, Netherlands, Republic, Spain, Switzerland, Thailand, The US Food Another extracted example is Mitapivat → Agios Netherlands, CHMP, Committee, EMA, European Medicines Agency, European Union, Human Use, In September, Medicinal Products, November, Pyrukynd. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
pyruvate kinase trial deficiency pyrukynd us salt blood participants approved medical medication ag-348 activator drug administration anemia names treatment brand
TTTA extracted 70 structured relationships around Mitapivat. Examples in this analysis include Mitapivat → 3D model (JSmol) → Interactive image and Mitapivat → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Mitapivat | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Mitapivat | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Mitapivat | ATC code | B06AX04 (WHO) | 1.00 | infobox |
| Mitapivat | CAS Number | 1260075-17-9 | 1.00 | infobox |
| Mitapivat | ChEMBL | ChEMBL4299940 | 1.00 | infobox |
| Mitapivat | ChEMBL | as salt: ChEMBL4297223 | 1.00 | infobox |
| Mitapivat | ChemSpider | 29763395 | 1.00 | infobox |
| Mitapivat | Drug class | Pyruvate kinase activator | 1.00 | infobox |
| Mitapivat | DrugBank | DB16236 | 1.00 | infobox |
| Mitapivat | DrugBank | as salt: DBSALT003215 | 1.00 | infobox |
| Mitapivat | Formula | C24H26N4O3S | 1.00 | infobox |
| Mitapivat | IUPHAR/BPS | 10473 | 1.00 | infobox |
| Mitapivat | KEGG | as salt: D11408 | 1.00 | infobox |
| Mitapivat | Legal status | US: ℞-only | 1.00 | infobox |
| Mitapivat | Legal status | EU: Rx-only | 1.00 | infobox |
| Mitapivat | License data | US DailyMed: Mitapivat | 1.00 | infobox |
| Mitapivat | MedlinePlus | a622018 | 1.00 | infobox |
| Mitapivat | Molar mass | 450.56 g·mol−1 | 1.00 | infobox |
| Mitapivat | Other names | AG-348, Mitapivat sulfate (USAN US) | 1.00 | infobox |
| Mitapivat | PubChem CID | 59634741 | 1.00 | infobox |
| Mitapivat | Routes of administration | By mouth | 1.00 | infobox |
| Mitapivat | Trade names | Pyrukynd | 1.00 | infobox |
| Mitapivat | UNII | 2WTV10SIKH | 1.00 | infobox |
| Mitapivat | UNII | as salt: N4JTA67V3O | 1.00 | infobox |
| Mitapivat | is a | pyruvate kinase activator.The most common side effects include decreases in estrone and estradiol | 0.90 | text |
The concept neighborhoods around Mitapivat bring nearby vocabulary together. In this analysis, examples include Kinase, Pyruvate and Approved. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Mitapivat, one of the stronger structural bridges in this analysis connects Mitapivat with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Mitapivat to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Community, Culture, Applications & Products, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Mitapivat · EN edition · Analysis: TopicsToTalkAbout
